Literature DB >> 29260457

Correction to: Tocilizumab: A Review in Rheumatoid Arthritis.

Lesley J Scott1.   

Abstract

The article Tocilizumab: A Review in Rheumatoid Arthritis, written by Lesley J. Scott, was originally published Online First without open access. After publication in volume 77, issue 17, pages 1865-1879 F. Hoffmann-La Roche Ltd requested that the article be Open Choice to make the article an open access publication. Post-publication open access was funded by F. Hoffmann-La Roche Ltd. Further details may be found at http://www.medengine.com/Redeem/68FBF06068F81EA7 . The article is forthwith distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits any noncommercial use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Entities:  

Year:  2018        PMID: 29260457      PMCID: PMC6828433          DOI: 10.1007/s40265-017-0856-4

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  2 in total

Review 1.  Pathogenesis and Function of Interleukin-35 in Rheumatoid Arthritis.

Authors:  Pan Lin Xin; Li Fan Jie; Qian Cheng; Du Yi Bin; Cheng Wen Dan
Journal:  Front Pharmacol       Date:  2021-05-13       Impact factor: 5.810

2.  Comparative Efficacy of Tocilizumab and Baricitinib Administration in COVID-19 Treatment: A Retrospective Cohort Study.

Authors:  Yuichi Kojima; Sho Nakakubo; Nozomu Takei; Keisuke Kamada; Yu Yamashita; Junichi Nakamura; Munehiro Matsumoto; Hiroshi Horii; Kazuki Sato; Hideki Shima; Masaru Suzuki; Satoshi Konno
Journal:  Medicina (Kaunas)       Date:  2022-04-04       Impact factor: 2.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.